| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/22/2006 | CA2587932A1 Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy |
| 06/22/2006 | CA2587589A1 Engineered antibodies and immunoconjugates |
| 06/21/2006 | EP1672072A2 Cloning and characterisation of the gene flbA of H. pylori; production of flagella-free strains |
| 06/21/2006 | EP1672070A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/21/2006 | EP1671981A2 Nucleic acids and proteins from streptococcus group A |
| 06/21/2006 | EP1671648A1 Prevention and treatment for gvhd |
| 06/21/2006 | EP1671645A1 Remedy and detection drug for bile duct cancer |
| 06/21/2006 | EP1671535A1 Methods for altering levels of phenolic compounds in plant cells |
| 06/21/2006 | EP1671534A1 Methods for altering levels of phenolic compounds in plant cells |
| 06/21/2006 | EP1671126A2 Diagnosis and treatment of mycobacterial infections |
| 06/21/2006 | EP1670912A2 Method for linking sequences of interest |
| 06/21/2006 | EP1670900A2 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 06/21/2006 | EP1670828A1 Fully human antibodies against human 4-1bb (cd137) |
| 06/21/2006 | EP1670827A2 Anti-ghrelin antibodies |
| 06/21/2006 | EP1670826A1 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 06/21/2006 | EP1670825A2 Antibodies to m-csf |
| 06/21/2006 | EP1670824A2 Norovirus monoclonal antibodies and peptides |
| 06/21/2006 | EP1670823A1 Chimeric mhc protein and oligomer thereof for specific targeting |
| 06/21/2006 | EP1670818A2 Piscirickettsia salmonis antigens and use thereof |
| 06/21/2006 | EP1670811A2 Shc proteins as therapeutic targets in proliferative diseases |
| 06/21/2006 | EP1670511A2 Cripto antagonism of activin and tgf-b signaling |
| 06/21/2006 | EP1670510A1 Antibodies against annexins, use thereof for therapy and diagnosis. use of annexins for therapy and diagnosis. |
| 06/21/2006 | EP1670508A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 06/21/2006 | EP1670505A2 Dna promoters and anthrax vaccines |
| 06/21/2006 | EP1670499A2 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 06/21/2006 | EP1670350A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 06/21/2006 | EP1629095A4 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 06/21/2006 | EP1385989A4 Il-1 inhibition for myeloma and related disorders |
| 06/21/2006 | EP1326895B8 Monoclonal antibodies directed against hepatitis b viruses |
| 06/21/2006 | EP1297151B1 14911 novel protein kinase molecules and uses therefor |
| 06/21/2006 | EP1192185B1 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1140170B1 Antibody fragments for the topical treatment of ocular diseases |
| 06/21/2006 | EP1007089B1 Anticoagulant humanised antibodies against factor IX, for use in the treatment of thrombosis |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | EP0912198B1 Immunoliposomes that optimize internalization into target cells |
| 06/21/2006 | EP0830456B1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
| 06/21/2006 | EP0811384B1 Muscle protein decomposition inhibitor containing il-6 receptor antibody |
| 06/21/2006 | EP0723663B1 Hybridoma and anti-kc-4 humanised monoclonal antibody, dna and rna encoding it, kit and diagnostic methods |
| 06/21/2006 | CN1791614A Construct comprising recognition domain of antibody against von Willebrand factor-specific cleaving enzyme |
| 06/21/2006 | CN1789416A Human artificial chromosome containing human antibody lambda light chain |
| 06/21/2006 | CN1789415A Recombined aquatic bird flu virus H5 subtype hemagglutinin, its preparation method and uses |
| 06/21/2006 | CN1789411A Isolated nucleic acid molecules which encode T cell inducible factors (TIF), the proteins encoded, and uses thereof |
| 06/21/2006 | CN1789284A Human interleukin 8 antagonist protein and preparation method thereof |
| 06/21/2006 | CN1789283A Artificial antigen, antibody of fenvalerate and uses thereof |
| 06/21/2006 | CN1789282A Multifunctional polypeptide |
| 06/21/2006 | CN1260367C Fortified fusion protein possessing angiopoiesis-inhibiting and anti-tumour actions |
| 06/21/2006 | CN1260360C Lipid kinase |
| 06/21/2006 | CN1260357C Improved anti-IgE antibodies and method of improving polypeptides |
| 06/21/2006 | CN1260249C Protein purification by ion exchange chromatography |
| 06/21/2006 | CN1259973C Preventives or remedies for psoriasis containing IL-6 antagonist as the active ingredient |
| 06/21/2006 | CN1259972C Anticoagulant agent and humanized anti-von willebrand factor monoclonal antibody |
| 06/20/2006 | USRE39138 antibodies used in enzyme-linked immunosorbent assays for detection of low density lipoproteins, immunoglobulins, collagen, serum and urinary peptides or proteins |
| 06/20/2006 | US7064244 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom |
| 06/20/2006 | US7064193 Therapeutic molecules |
| 06/20/2006 | US7064191 Process for purifying antibody |
| 06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
| 06/20/2006 | US7064189 Antibodies that immunospecifically bind to trail receptors |
| 06/20/2006 | US7064188 Monoclonal antibody for use in the detection of ovarian cancer |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064181 A nonapeptide containing an amino acid sequence: ala, pro, ala, his, arg, gly, arg, gly, gly, amide, ester or salt; ability to bind to a receptor protein of specific sequence |
| 06/20/2006 | US7064180 High affinity integrin polypeptides and uses thereof |
| 06/20/2006 | US7064106 Protein, as a reagent for screening a compound that inhibit the binding of the protein to insulin responsive aminopeptidase or to glucose transporter 4; useful as a preventive/remedy for hyperglycemia and diabetes melliuts etc. |
| 06/20/2006 | US7064105 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/20/2006 | US7063973 HDAC9 polypeptides and polynucleotides and uses thereof |
| 06/20/2006 | US7063964 Nucleic acids encoding IL-12 antibody |
| 06/20/2006 | US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 06/20/2006 | US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity |
| 06/20/2006 | US7063954 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 06/20/2006 | US7063953 Human voltage gated sodium channel β1A subunit and methods of use |
| 06/20/2006 | US7063949 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 06/20/2006 | US7063948 antibodies recognizing acetylcholinesterase or a C-terminal peptide derived from acetyl-cholinesterase, useful in diagnosing central nervous system stress |
| 06/20/2006 | US7063853 DNA immunization against Chlamydia infection |
| 06/20/2006 | US7063847 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/20/2006 | US7063845 Human anti-CD40 antibodies |
| 06/20/2006 | US7063844 Presentation of hydrophobic antigens to T-cells by CD1 molecules |
| 06/20/2006 | US7063842 Compounds and methods for inhibiting the interaction between α-catenin and β-catenin |
| 06/20/2006 | US7063841 Mammalian cell surface antigens; related reagents |
| 06/20/2006 | US7063840 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases |
| 06/20/2006 | CA2127700C Marek's disease virus recombinant poxvirus vaccine |
| 06/20/2006 | CA2049472C Monoclonal antibodies to leptosphaeria |
| 06/17/2006 | CA2585798A1 Process for the control of production of fine chemicals |
| 06/15/2006 | WO2006063292A1 Recombinant method for making multimeric proteins |
| 06/15/2006 | WO2006063150A2 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 06/15/2006 | WO2006062800A1 Monoclonal and polyclonal antibodies to equine hemoglobin and apparatus and methods using the antibodies and/or peroxidase reactions in the identification and localization of ulcers in equines |
| 06/15/2006 | WO2006062779A2 Anti-integrin immunoconjugates, methods and uses |
| 06/15/2006 | WO2006062118A1 Novel markers for predicting prognosis of papillary carcinoma of the thyroid |
| 06/15/2006 | WO2006062094A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | WO2006061650A2 Methods, products and uses involving platelets and/or the vasculature |
| 06/15/2006 | WO2006061242A2 Use of pta peptides for stratification of individuals having cancer |
| 06/15/2006 | WO2006047367A3 Suppression of endogenous immunoglubolin expression in non-human transgenic animals |
| 06/15/2006 | WO2006012351A3 Markers for brain damage |
| 06/15/2006 | WO2006009862A3 Amebiasis subunit vaccine |
| 06/15/2006 | WO2006004663A3 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 06/15/2006 | WO2005123923A3 Inducer specific tetracycline repressor proteins and methods of use thereof |
| 06/15/2006 | WO2005118635A3 Anti-cd3 antibodies and methods of use thereof |
| 06/15/2006 | WO2005117986A3 Antibody drug conjugates and methods |
| 06/15/2006 | WO2005100401A3 Monoclonal antibodies with specificity for fetal erythroid cells |
| 06/15/2006 | WO2005099756A3 ErbB ANTAGONISTS FOR PAIN THERAPY |